T0	Participants 45 75	X-linked retinitis pigmentosa:
T1	Participants 314 364	patients with X-linked retinitis pigmentosa (XLRP)
T2	Participants 686 750	Males (n = 78; 7-31 years) meeting entry criteria were enrolled.
T3	Participants 1733 1754	to patients with XLRP